- Home
- HII vs EXEL Comparison
HII vs EXEL Comparison
Compare HII & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HII
- EXEL
- Stock Information
- Founded
- HII 1886
- EXEL 1994
- Country
- HII United States
- EXEL United States
- Employees
- HII N/A
- EXEL N/A
- Industry
- HII Marine Transportation
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HII Industrials
- EXEL Health Care
- Exchange
- HII Nasdaq
- EXEL Nasdaq
- Market Cap
- HII 10.1B
- EXEL 10.4B
- IPO Year
- HII N/A
- EXEL 2000
- Fundamental
- Price
- HII $269.83
- EXEL $38.63
- Analyst Decision
- HII Hold
- EXEL Buy
- Analyst Count
- HII 9
- EXEL 21
- Target Price
- HII $260.13
- EXEL $43.65
- AVG Volume (30 Days)
- HII 497.7K
- EXEL 3.8M
- Earning Date
- HII 07-31-2025
- EXEL 07-28-2025
- Dividend Yield
- HII 2.03%
- EXEL N/A
- EPS Growth
- HII N/A
- EXEL 81.76
- EPS
- HII 13.36
- EXEL 2.08
- Revenue
- HII $11,569,000,000.00
- EXEL $2,230,005,000.00
- Revenue This Year
- HII $4.38
- EXEL $9.88
- Revenue Next Year
- HII $4.48
- EXEL $12.59
- P/E Ratio
- HII $20.21
- EXEL $18.60
- Revenue Growth
- HII N/A
- EXEL 10.73
- 52 Week Low
- HII $158.88
- EXEL $25.12
- 52 Week High
- HII $293.14
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- HII 59.01
- EXEL 45.22
- Support Level
- HII $262.66
- EXEL $37.40
- Resistance Level
- HII $267.93
- EXEL $38.78
- Average True Range (ATR)
- HII 5.15
- EXEL 0.85
- MACD
- HII -0.87
- EXEL 0.25
- Stochastic Oscillator
- HII 77.75
- EXEL 91.13
About HII Huntington Ingalls Industries Inc.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out of Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia and Columbia-class nuclear submarines. Huntington Ingalls shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's Mission Technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.